Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2006

Open Access 01-12-2006 | Research

Relationship of the metabolic syndrome to carotid ultrasound traits

Authors: Rebecca L Pollex, Khalid Z Al-Shali, Andrew A House, J David Spence, Aaron Fenster, Mary Mamakeesick, Bernard Zinman, Stewart B Harris, Anthony JG Hanley, Robert A Hegele

Published in: Cardiovascular Ultrasound | Issue 1/2006

Login to get access

Abstract

Background

The metabolic syndrome is associated with increased vascular disease risk. We evaluated two carotid ultrasound measurements, namely intima media thickness and total plaque volume, in a Canadian Oji-Cree population with a high metabolic syndrome prevalence rate.

Methods

As part of the Sandy Lake Complications Prevalence and Risk Factor Study, 166 Oji-Cree subjects (baseline metabolic syndrome prevalence, 44.0%, according to the National Cholesterol Education Program Adult Treatment Panel III guidelines) were examined using a high-resolution duplex ultrasound scanner.

Results

Image analysis showed that mean intima media thickness was elevated in subjects with the metabolic syndrome (818 ± 18 vs 746 ± 20 μm), as was total plaque volume (125 ± 26 vs 77.3 ± 17.0 mm3). However, after adjustment for age and sex, the differences were significant only for intima media thickness (P = 0.039). Furthermore, a significant trend towards increased intima media thickness was observed with increasing numbers of metabolic syndrome components: mean intima media thickness was highest among individuals with all five metabolic syndrome components compared to those with none (866 ± 55 vs 619 ± 23 μm, P = 0.0014). A similar, but non-significant trend was observed for total plaque volume.

Conclusion

This is the first study of the relationship between the metabolic syndrome and two distinct carotid ultrasound traits measured in the same individuals. The results suggest that standard intima media thickness measurement shows a more consistent and stronger association with the metabolic syndrome than does total plaque volume.
Appendix
Available only for authorised users
Literature
1.
go back to reference Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004, 25 (4): 342-348. 10.1016/j.ehj.2003.12.007CrossRefPubMed Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004, 25 (4): 342-348. 10.1016/j.ehj.2003.12.007CrossRefPubMed
2.
go back to reference Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28 (7): 1769-1778.CrossRefPubMed Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28 (7): 1769-1778.CrossRefPubMed
3.
go back to reference Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001, 24 (4): 683-689.CrossRefPubMed Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001, 24 (4): 683-689.CrossRefPubMed
4.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288 (21): 2709-2716. 10.1001/jama.288.21.2709CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288 (21): 2709-2716. 10.1001/jama.288.21.2709CrossRefPubMed
5.
go back to reference Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB: Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004, 93 (11A): 32C-48C. 10.1016/j.amjcard.2004.02.004CrossRefPubMed Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB: Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004, 93 (11A): 32C-48C. 10.1016/j.amjcard.2004.02.004CrossRefPubMed
6.
go back to reference Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD: 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke. 2005, 36 (9): 1904-1909. 10.1161/01.STR.0000178543.19433.20CrossRefPubMed Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD: 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke. 2005, 36 (9): 1904-1909. 10.1161/01.STR.0000178543.19433.20CrossRefPubMed
7.
go back to reference Pollex RL, Spence JD, House AA, Fenster A, Hanley AJ, Zinman B, Harris SB, Hegele RA: A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound. 2005, 3: 15- 10.1186/1476-7120-3-15CrossRefPubMedPubMedCentral Pollex RL, Spence JD, House AA, Fenster A, Hanley AJ, Zinman B, Harris SB, Hegele RA: A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound. 2005, 3: 15- 10.1186/1476-7120-3-15CrossRefPubMedPubMedCentral
8.
go back to reference Spence JD: Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002, 89 (4A): 10B-15B; discussion 15B-16B. 10.1016/S0002-9149(01)02327-XCrossRefPubMed Spence JD: Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002, 89 (4A): 10B-15B; discussion 15B-16B. 10.1016/S0002-9149(01)02327-XCrossRefPubMed
9.
go back to reference Al-Shali K, House AA, Hanley AJ, Khan HM, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, Hegele RA: Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis. 2005, 178 (2): 319-325. 10.1016/j.atherosclerosis.2004.08.016CrossRefPubMed Al-Shali K, House AA, Hanley AJ, Khan HM, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, Hegele RA: Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis. 2005, 178 (2): 319-325. 10.1016/j.atherosclerosis.2004.08.016CrossRefPubMed
10.
go back to reference Hegele RA, Al-Shali K, Khan HM, Hanley AJG, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, House AA: Carotid ultrasound in one, two and three dimension. Vasc Dis Prevention. 2005, 2: 87-92. 10.2174/1567270052774386. 10.2174/1567270052774386CrossRef Hegele RA, Al-Shali K, Khan HM, Hanley AJG, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, House AA: Carotid ultrasound in one, two and three dimension. Vasc Dis Prevention. 2005, 2: 87-92. 10.2174/1567270052774386. 10.2174/1567270052774386CrossRef
11.
go back to reference Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA: Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis. 2006, 184 (1): 121-129. 10.1016/j.atherosclerosis.2005.03.024CrossRefPubMed Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA: Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis. 2006, 184 (1): 121-129. 10.1016/j.atherosclerosis.2005.03.024CrossRefPubMed
12.
go back to reference Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Canada. 1995, 16: 149-156. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Canada. 1995, 16: 149-156.
13.
go back to reference Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B: Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr. 1998, 128 (3): 541-547.PubMed Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B: Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr. 1998, 128 (3): 541-547.PubMed
14.
go back to reference Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele R, Connelly PW, Shah B, Hux JE: The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract. 2002, 55 (2): 165-173. 10.1016/S0168-8227(01)00316-3CrossRefPubMed Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele R, Connelly PW, Shah B, Hux JE: The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract. 2002, 55 (2): 165-173. 10.1016/S0168-8227(01)00316-3CrossRefPubMed
15.
go back to reference Kriska AM, Hanley AJ, Harris SB, Zinman B: Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care. 2001, 24 (10): 1787-1792.CrossRefPubMed Kriska AM, Hanley AJ, Harris SB, Zinman B: Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care. 2001, 24 (10): 1787-1792.CrossRefPubMed
16.
go back to reference Hanley AJG, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, McLaughlin JR, Zinman B: Complications of type 2 diabetes among aboriginal Canadians: increasing our understanding of prevalence and risk factors. Canadian J Diabetes. 2003, 27: 455-463. Hanley AJG, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, McLaughlin JR, Zinman B: Complications of type 2 diabetes among aboriginal Canadians: increasing our understanding of prevalence and risk factors. Canadian J Diabetes. 2003, 27: 455-463.
17.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497.
18.
go back to reference Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH: Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis. 1994, 111 (1): 1-11. 10.1016/0021-9150(94)90186-4CrossRefPubMed Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH: Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis. 1994, 111 (1): 1-11. 10.1016/0021-9150(94)90186-4CrossRefPubMed
19.
go back to reference Landry A, Spence JD, Fenster A: Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke. 2004, 35 (4): 864-869. 10.1161/01.STR.0000121161.61324.abCrossRefPubMed Landry A, Spence JD, Fenster A: Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke. 2004, 35 (4): 864-869. 10.1161/01.STR.0000121161.61324.abCrossRefPubMed
20.
go back to reference McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004, 94 (10): 1249-1254. 10.1016/j.amjcard.2004.07.107CrossRefPubMed McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004, 94 (10): 1249-1254. 10.1016/j.amjcard.2004.07.107CrossRefPubMed
21.
go back to reference Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B: The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke. 2005, 36 (6): 1212-1217. 10.1161/01.STR.0000166196.31227.91CrossRefPubMed Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B: The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke. 2005, 36 (6): 1212-1217. 10.1161/01.STR.0000166196.31227.91CrossRefPubMed
22.
go back to reference Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997, 20 (2): 185-187.CrossRefPubMed Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care. 1997, 20 (2): 185-187.CrossRefPubMed
23.
go back to reference Al-Shali KZ, House AA, Hanley AJ, Khan HM, Harris SB, Zinman B, Mamakeesick M, Fenster A, Spence JD, Hegele RA: Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004, 35 (9): 2036-2040. 10.1161/01.STR.0000138784.68159.a5CrossRefPubMed Al-Shali KZ, House AA, Hanley AJ, Khan HM, Harris SB, Zinman B, Mamakeesick M, Fenster A, Spence JD, Hegele RA: Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke. 2004, 35 (9): 2036-2040. 10.1161/01.STR.0000138784.68159.a5CrossRefPubMed
24.
go back to reference Hegele RA, Al-Shali KZ, House AA, Hanley AJ, Harris SB, Mamakeesick M, Fenster A, Zinman B, Cao H, Spence JD: Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke. 2005, 36 (12): 2566-2570. 10.1161/01.STR.0000190833.43791.beCrossRefPubMed Hegele RA, Al-Shali KZ, House AA, Hanley AJ, Harris SB, Mamakeesick M, Fenster A, Zinman B, Cao H, Spence JD: Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke. 2005, 36 (12): 2566-2570. 10.1161/01.STR.0000190833.43791.beCrossRefPubMed
25.
go back to reference Wallenfeldt K, Hulthe J, Fagerberg B: The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med. 2005, 258 (1): 28-37. 10.1111/j.1365-2796.2005.01511.xCrossRefPubMed Wallenfeldt K, Hulthe J, Fagerberg B: The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med. 2005, 258 (1): 28-37. 10.1111/j.1365-2796.2005.01511.xCrossRefPubMed
Metadata
Title
Relationship of the metabolic syndrome to carotid ultrasound traits
Authors
Rebecca L Pollex
Khalid Z Al-Shali
Andrew A House
J David Spence
Aaron Fenster
Mary Mamakeesick
Bernard Zinman
Stewart B Harris
Anthony JG Hanley
Robert A Hegele
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2006
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-4-28

Other articles of this Issue 1/2006

Cardiovascular Ultrasound 1/2006 Go to the issue